Endowment / Foundation

Updated:

Society for Neuroscience

The Society for Neuroscience (SfN) was founded in 1969 as a professional body for scientists and physicians studying the brain and nervous system.

Society for Neuroscience logo

Society for Neuroscience

The Society for Neuroscience (SfN) was founded in 1969 as a professional body for scientists and physicians studying the brain and nervous system. The organization operates from its owned headquarters at 1121 14th Street NW in Washington, D.C., and is led by Executive Director Martin Saggese alongside President John Morrison for the 2024-2025 term. Unlike a family office, SfN's capital originates from membership dues, publication revenues, and its flagship annual meeting — making it an operating endowment rather than a vehicle for dynastic wealth. The investment portfolio, estimated at $78M (Altss estimate), spans a hybrid mandate covering buyout strategies and secondary transactions. The long-term investment pool and a strategic reserve pool are managed out of the Washington, D.C. office. While specific fund commitments or direct holdings are not publicly itemized, the office's posture places it among mid-sized institutional allocators that prioritize capital preservation and steady returns to underwrite scientific programming and advocacy. Grant-making partners on the programmatic side include the Chan Zuckerberg Initiative — co-investing in professional development and scientific rigor programs — and the Dana Foundation, which collaborates on public outreach and the BrainFacts.org platform. SfN's financial management falls under Senior Director of Finance and CFO Cori Spencer. Recent operational activity is quiet in the public domain; no major investment committee changes or new fund commitments have been reported in the last 24 months. The office participates in professional networks including the American Society of Association Executives (ASAE) and the Joint Steering Committee for Public Policy, though these do not function as co-investment clubs. The Pershing Square Foundation has been a grant provider, reinforcing SfN's connectivity to allocators who also deploy philanthropic capital. SfN's structural differentiator is the clean wall between its mission-driven programming and its invested financial reserves. Unlike a university endowment that funds a single institution's operations, SfN's portfolio supports a global scientific society. Investment decisions serve a constituency of 36,000 members, with no single family or donor controlling allocation strategy — creating a governance model where the finance function is accountable to a rotating scientific presidency rather than a permanent investment committee dynast.

General information

Firm type

Endowment / Foundation

Year founded

1969

Location

Region

North America

Country

United States

City

Washington

Corporate office

1121 14th Street NW, Suite 1010, Washington, DC 20005, United States

Principals

Martin Saggese

Executive Director

Cori Spencer

Chief Financial Officer

John Morrison

President (2024-2025 term)

Frequently asked questions

Who runs investment decisions at the Society for Neuroscience?

Financial oversight sits with Cori Spencer, Senior Director of Finance and Management Services and CFO, under Executive Director Martin Saggese. The investment program operates without a publicly named chief investment officer, suggesting either an outsourced chief investment officer (OCIO) arrangement or a tight internal finance committee that does not disclose its members.

Where does the Society for Neuroscience's investment capital come from?

The capital base is organic — revenue from membership dues, the society's flagship annual meeting, and its scientific publications including The Journal of Neuroscience. There is no founding family wealth or large single-donor endowment behind the portfolio, making SfN a pure operating endowment.

How is the investment function separated from the grant-making activity?

SfN maintains a structural separation between its long-term investment portfolio and its programmatic grant partnerships. The Chan Zuckerberg Initiative and Dana Foundation co-invest on the programming side through professional development and public outreach grants, while the strategic reserve pool is managed independently to support the society's operational continuity.

Does the Society for Neuroscience participate in fund commitments or direct deals?

The published strategy tags — buyout, hybrid, secondaries — point toward a mix of fund commitments and secondary market purchases. No specific general partner relationships or direct co-investment names have been made public.

What is the Society for Neuroscience's known posture on co-investments alongside external allocators?

SfN does not operate a co-investment club or open its deal flow to peer allocators. Its external financial relationships are through grant providers like the Pershing Square Foundation rather than through investment syndicates. The office is a consumer of fund products, not a deal-by-deal co-investor alongside families or other endowments.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on endowments & foundations?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Washington Endowment / Foundation profiles